Fatty liver disease: Should you be tested?
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
C. Michael Gibson, MD
Contributor
Dr. C. Michael Gibson is a professor of medicine at Harvard Medical School and an interventional cardiologist at Beth Israel Deaconess Medical Center. He is the CEO of the combined nonprofit Baim and PERFUSE research institutes at Harvard Medical School. He has published hundreds of papers and led major trials that resulted in the approval of key cardiovascular drugs. His research focuses on thrombosis, atherosclerosis, acute coronary syndromes, atrial fibrillation, implantable monitors, and artificial intelligence.
After earning his medical degree at the University of Chicago Pritzker School of Medicine, Dr. Gibson did his internship, residency, and chief residency at Brigham and Women's Hospital and completed a cardiology fellowship at Beth Israel Deaconess Medical Center.
Fatty liver disease: Should you be tested?
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
